Evidence map›Paper›PMID 42709961›Full record

ArticleEndocrinology, diabetes & metabolism case reports2026

Significantly elevated calcium levels and gallstone disease in a patient with familial hypocalciuric hypercalcaemia.

Adam Sabo, Andrew McGovern

Abstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Adam SaboNorth Devon District Hospital , Barnstaple, UK.ORCID 0009-0001-0878-0182
Andrew McGovernUniversity of Exeter Institute of Biomedical and Clinical Science , Exeter, UK.ORCID 0000-0002-6833-9399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summaryFamilial hypocalciuric hypercalcaemia (FHH) is a rare, benign genetic disorder of calcium homeostasis caused by inactivating variants in CaSR, GNA11, or AP2S1 genes. It is typically characterised by mild, asymptomatic hypercalcaemia and low urinary calcium excretion. Differentiation from primary hyperparathyroidism (PHPT) is essential, as misdiagnosis can lead to unnecessary surgery. We report a case of FHH type 1 (FHH1) in a man in his thirties presenting with a serum calcium level of 2.97 mmol/L, which is at the severe end of the FHH spectrum. Genetic testing revealed a heterozygous CaSR nonsense variant (NM_000388.4:c.1942C>T, p.Arg648Ter) consistent with FHH1. The patient had clinically stable hypercalcaemia, which was not treated. During follow-up, he developed gallstones treated with a laparoscopic cholecystectomy. A review of the literature demonstrated that calcium levels approaching 3 mmol/L, although uncommon, have been reported in other cases of FHH1. We review the literature regarding a potential association between FHH and gallstones. This case highlights that FHH can present with relatively marked hypercalcaemia, reinforcing the need for genetic evaluation before surgery, and suggests a possible but under-explored relationship between FHH and gallstone disease. LEARNING POINTS:

Indexed as

calciumrare diseases/syndromes

Identifiers

PMID42709961
PMCPMC13588474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.